PMV Pharmaceuticals, Inc. (PMVP) Earnings History
Annual and quarterly earnings data from 2018 to 2024
Loading earnings history...
PMVP EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
PMVP Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export PMVP earnings history in CSV or JSON format
Free sign-in required to download data
PMV Pharmaceuticals, Inc. (PMVP) Earnings Overview
As of May 8, 2026, PMV Pharmaceuticals, Inc. (PMVP) reported trailing twelve-month net income of -$83M, reflecting +21.0% year-over-year growth. The company earned $-1.56 per diluted share over the past four quarters.
Looking at the long-term picture, PMVP's historical earnings data spans multiple years. The company achieved its highest annual net income of -$18M in fiscal 2018.
PMV Pharmaceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RAIN (-$6M net income), KYMR (-$315M net income, -794.4% margin), TNGX (-$102M net income, -162.9% margin), PMVP has comparable earnings metrics. Compare PMVP vs RAIN →
PMVP Earnings vs Peers
Earnings metrics vs comparable public companies
PMVP Historical Earnings Data (2018–2024)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$59M | +14.9% | -$85M | $-1.14 | - | - |
| 2023 | -$69M | +5.9% | -$80M | $-1.44 | - | - |
| 2022 | -$73M | -26.7% | -$77M | $-1.61 | - | - |
| 2021 | -$58M | -68.0% | -$58M | $-1.28 | - | - |
| 2020 | -$34M | -35.8% | -$35M | $-2.40 | - | - |
| 2019 | -$25M | -44.6% | -$27M | $-0.59 | - | - |
| 2018 | -$18M | - | -$19M | $-5.80 | - | - |
See PMVP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PMVP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PMVP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPMVP — Frequently Asked Questions
Quick answers to the most common questions about buying PMVP stock.
Is PMVP growing earnings?
PMVP EPS is $-1.56, with earnings growth accelerating to +21.0%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-83M.
What are PMVP's profit margins?
PMV Pharmaceuticals, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are PMVP's earnings?
PMVP earnings data spans 2018-2024. The accelerating earnings trend is +21.0% YoY. Historical data enables comparison across business cycles.